Manulife (Manufacturers Life Insurance)’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$548K Buy
22,943
+213
+0.9% +$5.09K ﹤0.01% 2136
2025
Q1
$565K Buy
22,730
+5,808
+34% +$144K ﹤0.01% 2085
2024
Q4
$319K Sell
16,922
-458
-3% -$8.63K ﹤0.01% 2422
2024
Q3
$262K Sell
17,380
-6,552
-27% -$98.6K ﹤0.01% 2544
2024
Q2
$685K Buy
23,932
+1,354
+6% +$38.7K ﹤0.01% 2061
2024
Q1
$660K Sell
22,578
-203
-0.9% -$5.93K ﹤0.01% 2072
2023
Q4
$769K Sell
22,781
-453
-2% -$15.3K ﹤0.01% 1956
2023
Q3
$713K Buy
23,234
+4,796
+26% +$147K ﹤0.01% 1943
2023
Q2
$739K Buy
18,438
+429
+2% +$17.2K ﹤0.01% 1814
2023
Q1
$735K Buy
18,009
+120
+0.7% +$4.9K ﹤0.01% 1774
2022
Q4
$691K Buy
17,889
+135
+0.8% +$5.21K ﹤0.01% 1799
2022
Q3
$944K Sell
17,754
-258
-1% -$13.7K ﹤0.01% 1631
2022
Q2
$1.05M Sell
18,012
-70
-0.4% -$4.08K ﹤0.01% 1627
2022
Q1
$1.38M Sell
18,082
-4,289
-19% -$327K ﹤0.01% 1614
2021
Q4
$1.35K Sell
22,371
-362
-2% -$22 ﹤0.01% 1659
2021
Q3
$1.27M Sell
22,733
-1,801
-7% -$101K ﹤0.01% 1689
2021
Q2
$1.49M Buy
24,534
+490
+2% +$29.7K ﹤0.01% 1748
2021
Q1
$1.69M Sell
24,044
-1,332
-5% -$93.3K ﹤0.01% 1623
2020
Q4
$1.52M Buy
25,376
+1,064
+4% +$63.6K ﹤0.01% 1632
2020
Q3
$1.46M Sell
24,312
-338
-1% -$20.3K ﹤0.01% 1522
2020
Q2
$1.28M Sell
24,650
-1,377
-5% -$71.6K ﹤0.01% 1526
2020
Q1
$873K Buy
26,027
+1,652
+7% +$55.4K ﹤0.01% 1572
2019
Q4
$1.1M Sell
24,375
-697
-3% -$31.6K ﹤0.01% 1624
2019
Q3
$1M Sell
25,072
-310
-1% -$12.4K ﹤0.01% 1641
2019
Q2
$1.1M Sell
25,382
-860
-3% -$37.4K ﹤0.01% 1594
2019
Q1
$999K Buy
26,242
+1,525
+6% +$58.1K ﹤0.01% 1694
2018
Q4
$1.06M Sell
24,717
-1,479
-6% -$63.6K ﹤0.01% 1563
2018
Q3
$1.29M Sell
26,196
-3,841
-13% -$189K ﹤0.01% 1648
2018
Q2
$963K Buy
30,037
+235
+0.8% +$7.53K ﹤0.01% 1914
2018
Q1
$928K Sell
29,802
-211
-0.7% -$6.57K ﹤0.01% 1888
2017
Q4
$1.37M Buy
30,013
+79
+0.3% +$3.61K ﹤0.01% 1669
2017
Q3
$1.12M Sell
29,934
-373
-1% -$14K ﹤0.01% 1714
2017
Q2
$1.45M Buy
30,307
+1,872
+7% +$89.3K ﹤0.01% 1594
2017
Q1
$1.3M Buy
28,435
+3,439
+14% +$157K ﹤0.01% 1612
2016
Q4
$807K Buy
24,996
+84
+0.3% +$2.71K ﹤0.01% 1782
2016
Q3
$853K Buy
24,912
+57
+0.2% +$1.95K ﹤0.01% 1734
2016
Q2
$838K Buy
24,855
+693
+3% +$23.4K ﹤0.01% 1718
2016
Q1
$1.23M Buy
24,162
+287
+1% +$14.6K ﹤0.01% 1523
2015
Q4
$1.83K Buy
23,875
+250
+1% +$19 ﹤0.01% 1409
2015
Q3
$971 Buy
23,625
+647
+3% +$27 ﹤0.01% 1616
2015
Q2
$1.63K Sell
22,978
-37,942
-62% -$2.68K ﹤0.01% 1468
2015
Q1
$5.41K Sell
60,920
-3,877
-6% -$344 0.01% 1007
2014
Q4
$5.75K Buy
64,797
+41,669
+180% +$3.69K 0.01% 917
2014
Q3
$2.24K Buy
23,128
+582
+3% +$56 ﹤0.01% 1294
2014
Q2
$2.07M Buy
22,546
+1,570
+7% +$144K ﹤0.01% 1317
2014
Q1
$1.47K Sell
20,976
-149
-0.7% -$10 ﹤0.01% 1430
2013
Q4
$1.21K Sell
21,125
-668
-3% -$38 ﹤0.01% 1502
2013
Q3
$1.05K Sell
21,793
-883
-4% -$43 ﹤0.01% 1530
2013
Q2
$658K Buy
+22,676
New +$658K ﹤0.01% 1717